Betta Pharmaceuticals Market Cap

Betta Pharmaceuticals has a market cap or net worth of 18.28 billion as of March 9, 2026. Its market cap has decreased by -24.36% in one year.

Market Cap

18.28B

Enterprise Value

20.33B

Revenue

3.26B

Ranking

n/a

PE Ratio

60.31

Stock Price

43.45

Market Cap Chart

Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 18.28B, an increase of 80.19%. That is a compound annual growth rate of 6.51%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	18.52B	-5.74%
Dec 31, 2025	19.64B	-12.96%
Dec 31, 2024	22.57B	4.62%
Dec 29, 2023	21.57B	5.11%
Dec 30, 2022	20.53B	-38.09%
Dec 31, 2021	33.15B	-25.26%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Walvax Biotechnology	18.68B
China Resources Double-Crane Pharmaceutical	18.79B
Shandong Buchang Pharmaceuticals	17.63B
Tonghua Dongbao Pharmaceutical	17.57B
Zhejiang Medicine	17.42B
Wedge Industrial	19.89B
Fujian Cosunter Pharmaceutical	17.04B
Apeloa Pharmaceutical Co.,Ltd	20.32B

Market Cap Rankings